News about cell analysis instruments and tools including flow cytometry, cell counters, high content screening, etc.
AUSTIN, Texas, Oct. 18, 2018 /PRNewswire/ — Luminex Corporation (NASDAQ: LMNX) today announced that the company has signed a definitive agreement to acquire MilliporeSigma’s flow cytometry portfolio for $75 million, consisting of approximately $69.9 million to be paid under a Stock and Asset Purchase Agreement and approximately $5.1 million in committed inventory purchases. The deal... Read more
AUSTIN, Texas, Oct. 18, 2018 /PRNewswire/ — Luminex Corporation (NASDAQ: LMNX) today announced that the company has signed a definitive agreement to acquire MilliporeSigma’s flow cytometry portfolio for $75 million, consisting of approximately $69.9 million to be paid under a Stock and Asset Purchase Agreement and approximately $5.1 million in committed inventory purchases. The deal... Read more
Phase II grant to support development of innovative exosome characterization platform BOSTON, Sept. 27, 2018 /PRNewswire/ — NanoView Biosciences, an emerging leader in the field of exosome characterization, has been awarded a National Science Foundation Small Business Innovation Research Phase II grant in the amount of $750,000. The program will focus on completing development of the ExoView™ system, the company’s... Read more
https://www.nanion.de/images/Downloads_pdf/Press_Releases/180926_PR_Charles_River.pdf Livingston, N.J., Munich, Germany, September 26, 2018: Nanion announced today that Charles River Laboratories has purchased two SyncroPatch 384PE high-throughput patch clamp instruments. This purchase reflects an investment in screening technologies and assay development, while accommodating the rising demand in contract service for globally shared clients. The instruments will be delivered to Charles... Read more
VIVIAN CAO SEPTEMBER 26, 2018 ACEA Biosciences announced today that it has signed a definitive agreement to join Agilent Technologies, Inc. (NYSE: A). ACEA Biosciences is a company known for developing highly innovative products, which are used in academia, as well as the biotech and pharmaceutical industries. In recent years, the ACEA xCELLigence® RTCA technology has... Read more
Agilent to Expand Portfolio and Capabilities in Cell Analysis with Acquisition of ACEA Biosciences SANTA CLARA, Calif., September 25, 2018 Highlights: Acquisition adds a differentiated portfolio and organizational capabilities in the fast-growing cell analysis market Combined portfolio expands cell-based applications and workflows allowing customers more choices to answer more questions from a single sample Combined... Read more
IsoPlexis’ groundbreaking platform has been shown in key studies to predict patient response to cell therapy The IsoLight® platform: • profiles responses at the single cell level enabling researchers to generate a precise functional patient signature to help predict and understand complex patient response to cancer immunotherapies • advances high-need areas of cell therapy research,... Read more
September 17, 2018 02:07 AM Pacific Daylight Time CAMBRIDGE, England–(BUSINESS WIRE)–Sphere Fluidics, a company commercializing single cell analysis systems underpinned by its patented picodroplet technology, today introduced Cyto-Mine® Studio Software Suite, an updated software for its innovative Cyto-Mine Single Cell Analysis System. The software works alongside industry-standard robotic platforms and corporate databases to improve antibody discovery... Read more
Basel, Switzerland – MipTec Exhibition – (12 September 2018) – Proteins are the building blocks of life. They form the structure of cells, regulate cellular activity and carry out the biochemical processes that underpin function in every living organism. To understand proteins and their function, we must understand the way they fold, aggregate and interact.... Read more
Cologne (DE)/Walkersville, MD (USA), 6 September 2018 – Today, Lonza announced the release of a new technical note that provides toxicity, wound healing and cosmetic researchers with a faster method for constructing three-dimensional (3D) full-thickness skin models that closely resemble native skin. Compared with its two-dimensional (2D) counterpart, 3D cell culture is increasingly being recognized... Read more